Science
Mechanism of Action
This active compound functions as a robust antioxidant, demonstrating significant peroxyl radical scavenging activity and potent xanthine oxidase inhibition (IC50 of 0.2 µM). It also exhibits anti-inflammatory effects by inhibiting nitric oxide synthesis in skin cells, providing cytoprotection. For skin brightening, Purpurogallin intervenes in melanogenesis by reducing tyrosinase activity and downregulating the expression of critical melanin-producing enzymes (tyrosinase, TRP-1, TRP-2) and the master transcription factor MITF.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 In melanoma cells, concentrations ranging from 2.5 µM to 25 µM demonstrated concentration-dependent inhibition of tyrosinase activity and melanin biosynthesis. At 25 µM, over 20% inhibition of tyrosinase activity and 20% inhibition of melanin biosynthesis were observed, leading to approximately 50% melanin reduction compared to control, with cell survival maintained at 80% or higher.
- 02 At 25 µM, Purpurogallin significantly reduced the protein expression of key melanogenesis-related factors in melanoma cells: tyrosinase by approximately 10%, TRP-1 by 25%, TRP-2 by 20%, and the transcription factor MITF by 15%.
Transparency
Dusting Analysis
Purpurogallin is commonly handled and stored in powder form, and GHS hazard statements indicate it 'May cause respiratory irritation,' suggesting caution is warranted during handling and manufacturing processes where airborne particles could be generated.
The Formula
Formulation
Stability
Solutions of Purpurogallin are inherently unstable, necessitating fresh preparation or acquisition in small, pre-packaged quantities. For extended storage, the ingredient should be repackaged and maintained as a powder at -20°C for up to 3 years.
Safety
Safety Profile
GHS Hazard Statements indicate Purpurogallin 'Causes skin irritation' and 'Causes serious eye irritation,' suggesting a moderate to high risk of irritation, particularly at higher concentrations or in undiluted forms. While its precursor, Pyrogallol, faced regulatory concerns and was banned in EU cosmetics, this information pertains to Pyrogallol directly and not Purpurogallin, though it may prompt additional scrutiny due to structural similarities.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While Purpurogallin demonstrates promising in vitro efficacy in melanin inhibition and antioxidant protection, the lack of human clinical studies, unreviewed safety status by CIR, and explicit GHS irritation warnings necessitate further investigation before widespread recommendation for precision skincare.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources